Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly
Evangelos J. Giamarellos-Bourboulis, Maria Tsilika, Simone Moorlag, Nikolaos Antonakos, Antigone Kotsaki, Jorge Domínguez-Andrés, Evdoxia Kyriazopoulou, Theologia Gkavogianni, Maria-Evangelia Adami, Georgia Damoraki, Panagiotis Koufargyris, Athanassios Karageorgos, Amalia Bolanou, Hans Koenen, Reinout van Crevel, Dionyssia-Irene Droggiti, George Renieris, Antonios Papadopoulos, Mihai G Netea Cell 2020 Oct 15;183(2):315-323 DOI: 10.1016/j.cell.2020.08.051Download pdf
Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group
Dimitrios Velissaris, George Dimopoulos, John Parissis, Zoi Alexiou, Nikolaos Antonakos, Dimitrios Babalis, Styliani Gerakari, Vassileios Kaldis, Pantelis Koutoukas, Malvina Lada, Konstantinos Leventogiannis, Ioannis Pantazopoulos, Antonios Papadopoulos, Eftihia Polyzogopoulou, Charalambos Gogos, Apostolos Armaganidis, Evangelos J. Giamarellos-Bourboulis Infectious Diseases and Therapy 2020 Sep;9(3):407-416 DOI: 10.1007/s40121-020-00301-wDownload pdf 🡇 Funding The study
Impact of comorbidities on the performance of interferon-gamma release assay in an elderly Greek population without overt immunodeficiency
Maria Tsilika, Nikolaos Antonakos, Theologia Gkavogianni, Athanassios Karageorgos, Evdoxia Kyriazopoulou, Mihai G Netea, Evangelos J. Giamarellos-Bourboulis International Journal of Antimicrobial Agents 2020 Sep;56(3):106073 DOI 10.1016/j.ijantimicag.2020.106073 View article 🡇 Funding The ACTIVATE study was supported by an ERC Advanced Grant (#833247, to MGN). MGN was also
Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis
George Dimopoulos, Quirijn de Mast, Nikolaos Markou, Maria Theodorakopoulou, Apostolos Komnos, Maria Mouktaroudi, Mihai G Netea, Themistoklis Spyridopoulos, Rebecca J Verheggen, Jacobien Hoogerwerf, Alexandra Lachana, Frank L van de Veerdonk, Evangelos J. Giamarellos-Bourboulis Cell Host & Microbe 2020 Jul 8;28(1):117-123.e1 DOI 10.1016/j.chom.2020.05.007Download pdf 🡇 Funding The study was
MABp1 targeting interleukin-1α in hidradenitis suppurativa ineligible for adalimumab treatment: results of the open-label extension period
Theodora Kanni, Maria Argyropoulou, Charles A Dinarello, John Simard, Evangelos J. Giamarellos-Bourboulis Clinical and Experimental Dermatology 2021 Jan;46(1):162-163 DOI: 10.1111/ced.14333 View article 🡇 Funding XBiotech, Texas Hellenic Sepsis Study Group Keywords: Hidradenitis Suppurativa Related Study: HIDRA04
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Evangelos J. Giamarellos-Bourboulis, Mihai G Netea, Nikoletta Rovina, Karolina Akinosoglou, Anastasia Antoniadou, Nikolaos Antonakos, Georgia Damoraki, Theologia Gkavogianni, Maria-Evangelia Adami, Paraskevi Katsaounou, Maria Ntaganou, Magdalini Kyriakopoulou, George Dimopoulos, Ioannis Koutsodimitropoulos, Dimitrios Velissaris, Panagiotis Koufargyris, Athanassios Karageorgos, Konstantina Katrini, Vasileios Lekakis, Mihaela Lupse, Antigone Kotsaki, George Renieris, Danai Theodoulou, Vassiliki